Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07507825 Background | Mar 2026 → Mar 2028 expected | acute myeloid leukemia | First People's Hospital of Hangzhou | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07507825 ↗ |
| Route | Subcutaneous | “Subcutaneous administration of G-CSF” NCT07507825 ↗ |